These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 16227166)
1. Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer. Salminen E; Ala-Houhala M; Korpela J; Varpula M; Tiitinen SL; Halleen JM; Väänänen HK Acta Oncol; 2005; 44(7):742-7. PubMed ID: 16227166 [TBL] [Abstract][Full Text] [Related]
2. Survival markers related to bone metastases in prostate cancer. Salminen EK; Kallioinen MJ; Ala-Houhala MA; Vihinen PP; Tiitinen SL; Varpula M; Vahlberg TJ Anticancer Res; 2006; 26(6C):4879-84. PubMed ID: 17214355 [TBL] [Abstract][Full Text] [Related]
3. Serum TRACP 5b and ICTP as markers of bone metastases in breast cancer. Korpela J; Tiitinen SL; Hiekkanen H; Halleen JM; Selander KS; Väänänen HK; Suominen P; Helenius H; Salminen E Anticancer Res; 2006; 26(4B):3127-32. PubMed ID: 16886645 [TBL] [Abstract][Full Text] [Related]
4. Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer. Ozu C; Nakashima J; Horiguchi Y; Oya M; Ohigashi T; Murai M Int J Urol; 2008 May; 15(5):419-22. PubMed ID: 18452459 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients. Tang C; Liu Y; Qin H; Li X; Guo W; Li J; Wang W; Qu L; Hu H; Xu C; Zheng L; Huang Y; Liu B; Gao H; Halleen JM; Liu X Clin Chim Acta; 2013 Nov; 426():102-7. PubMed ID: 24055775 [TBL] [Abstract][Full Text] [Related]
6. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma. Terpos E; de la Fuente J; Szydlo R; Hatjiharissi E; Viniou N; Meletis J; Yataganas X; Goldman JM; Rahemtulla A Int J Cancer; 2003 Sep; 106(3):455-7. PubMed ID: 12845688 [TBL] [Abstract][Full Text] [Related]
7. Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients. Mose S; Menzel C; Kurth AA; Obert K; Breidert I; Borowsky K; Böttcher HD Anticancer Res; 2003; 23(3C):2783-8. PubMed ID: 12926113 [TBL] [Abstract][Full Text] [Related]
8. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption. Halleen JM Anticancer Res; 2003; 23(2A):1027-9. PubMed ID: 12820342 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of tartrate-resistant acid phosphatase (TRACP) 5b as bone resorption marker in irradiated bone metastases. Mose S; Menzel C; Kurth AA; Obert K; Ramm U; Eberlein K; Boettcher HD; Pichlmeier U Anticancer Res; 2005; 25(6C):4639-45. PubMed ID: 16334155 [TBL] [Abstract][Full Text] [Related]
11. Serum tartrate resistant acid phosphatase as a potential marker of bone metastasis from breast cancer. Wada N; Ishii S; Ikeda T; Enomoto K; Kitajima M Anticancer Res; 1999; 19(5C):4515-21. PubMed ID: 10650803 [TBL] [Abstract][Full Text] [Related]
12. Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients. Chao TY; Ho CL; Lee SH; Chen MM; Janckila A; Yam LT J Biomed Sci; 2004; 11(4):511-6. PubMed ID: 15153786 [TBL] [Abstract][Full Text] [Related]
13. Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis. Chao TY; Wu YY; Janckila AJ Clin Chim Acta; 2010 Nov; 411(21-22):1553-64. PubMed ID: 20599857 [TBL] [Abstract][Full Text] [Related]
14. Potential role of tartrate-resistant acid phosphatase 5b (TRACP 5b) as a surrogate marker of late loosening in patients with total hip arthroplasty: a cohort study. Savarino L; Avnet S; Greco M; Giunti A; Baldini N J Orthop Res; 2010 Jul; 28(7):887-92. PubMed ID: 20063383 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth. Chen CJ; Chao TY; Janckila AJ; Cheng SN; Ku CH; Chu DM J Pediatr Endocrinol Metab; 2005 Jan; 18(1):55-62. PubMed ID: 15679069 [TBL] [Abstract][Full Text] [Related]
16. Tartrate-resistant acid phosphatase as a marker of bone metastases in patients with breast cancer and prostate cancer. Lyubimova NV; Pashkov MV; Tyulyandin SA; Gol'dberg VE; Kushlinskii NE Bull Exp Biol Med; 2004 Jul; 138(1):77-9. PubMed ID: 15514730 [TBL] [Abstract][Full Text] [Related]
17. Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients. Yao NS; Wu YY; Janckila AJ; Ku CH; Hsieh AT; Ho CL; Lee SH; Chao TY Clin Chim Acta; 2011 Jan; 412(1-2):181-5. PubMed ID: 20932965 [TBL] [Abstract][Full Text] [Related]
18. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Halleen JM; Tiitinen SL; Ylipahkala H; Fagerlund KM; Väänänen HK Clin Lab; 2006; 52(9-10):499-509. PubMed ID: 17078477 [TBL] [Abstract][Full Text] [Related]
19. Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases. Wakabayashi H; Nakajima K; Mizokami A; Namiki M; Inaki A; Taki J; Kinuya S Ann Nucl Med; 2013 Nov; 27(9):802-7. PubMed ID: 23828554 [TBL] [Abstract][Full Text] [Related]
20. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide. Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]